Acceptance and Commitment Therapy (ACT) vs Erenumab for High Frequency Episodic Migraine Without Aura: Time to Take the Gloves Off!
Headache
; 60(4): 804-806, 2020 04.
Article
in En
| MEDLINE
| ID: mdl-32096558
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Outcome Assessment, Health Care
/
Migraine without Aura
/
Antibodies, Monoclonal, Humanized
/
Acceptance and Commitment Therapy
/
Calcitonin Gene-Related Peptide Receptor Antagonists
Type of study:
Clinical_trials
Limits:
Adult
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Headache
Year:
2020
Document type:
Article
Affiliation country:
Italy